LA JOLLA, Calif.–LAWFUEL – Class Action Law News –The Law firm of…

LA JOLLA, Calif.–LAWFUEL – Class Action Law News –The Law firm of Blumenthal & Markham announces a Proposed Class Action Settlement regarding the unlawful distribution of “PC-Spes”.

This case, called Mittleholtz v. International Medical Research, Inc., Sophie Chen, John Chen, and Allan Wang (“IMR Defendants”), et al., case No. GIC846200, is a class action lawsuit that alleges that the IMR Defendants unlawfully distributed a product containing synthetic chemicals, the presence of which was also concealed from the public as a result of the IMR Defendants’ alleged failure to conduct any testing for adulteration by synthetic chemicals, including but not limited to diethylstilbestrol (DES) and warfarin (or coumadin), which is the active chemical in bloodthinners. Defendants deny the allegations. The Court has not formed any opinions concerning the merits of the lawsuit nor has it ruled for or against the Plaintiffs as to any of their claims. The sole purpose of this notice is to inform you of the lawsuit so that you may make an informed decision as to whether you wish to remain in or opt out of this class action.

You have legal rights and choices in this case. You can:

Join the case. You do not have to do or pay anything to be part of this case. And, you have to accept the final result in the case.
Exclude yourself and file your own lawsuit. If you want your own lawyer, you will have to exclude yourself as set forth below and pay your lawyer’s fees and costs.
Exclude yourself and not sue. If you do not wish to be part of this case and do not want to bring your own lawsuit, please mail a first class letter stating that you want to be excluded from the Mittleholtz v IMR class action (Case No. GIC846200), or you may fill out the letter available at Make sure the letter has your full name, address and signature. Mail it to: PC-SPES Litigation, Class Administrator, c/o Gilardi & Co. LLC, P.O. Box 8060, San Rafael, CA 94912-8060 by March 23, 2007.
*This is only a summary. For complete notice and further information go to: or call the toll-free number 1-877-800-7853.

Scroll to Top